The Danish drugmaker’s move follows a similar announcement by rival Eli Lilly earlier this month. More than 8 million Americans use insulin, according to the American Diabetes Association.
(Image credit: Mel Evans/AP)
Novo Nordisk will cut some U.S. insulin prices by up to 75% starting next year
